An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.

J Alzheimers Dis · 2020 · PMC7081093 · PMID 31884472

Europe PMC DOI

hedged sentence

0.0260

closest p · 0.5× alpha

0.0260

boldest claim

The sentences

a significant trendp = 0.026actually significant

There is a significant trend (R 2 = 0.998, p = 0.026) from 10 mg (70 voxels), to 30 mg (518 voxels), to 90 mg (2136 voxels).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.